Washington State Expands Access to Abortion Medication, Addresses Stockpile Distribution

OLYMPIA – The Washington State Senate has passed legislation aimed at streamlining the distribution of the state’s stockpile of abortion medication, addressing logistical challenges and ensuring the medication doesn’t expire unused. Senate Bill 5917, approved Tuesday, grants the Department of Corrections (DOC) greater flexibility in how it distributes mifepristone and misoprostol to healthcare providers.

Addressing Initial Stockpile Challenges

The legislation stems from a proactive effort by former Governor Jay Inslee in 2023, who directed the DOC to purchase a significant supply of these medications in anticipation of potential legal challenges to federal abortion access. The DOC acquired 30,000 doses of mifepristone in April 2023, followed by an additional 17,600 doses of mifepristone and 155,000 doses of misoprostol shortly before Inslee left office. The total cost of these purchases reached approximately $2 million [Spokesman.com].

New Legislation Allows for Flexible Pricing

Initially, the DOC was required to sell the medication at cost. However, lawmakers discovered that many healthcare providers could obtain the medication at a lower price, making it financially unfeasible for them to purchase from the state stockpile. SB 5917 removes the requirement to sell at cost, allowing the DOC to accept any amount of payment, or no payment at all, for the medication it distributes [Spokesman.com]. This change aims to encourage wider distribution and prevent the medication from expiring.

Logistical Hurdles and the Role of the Department of Health

Senator Jessica Bateman (D-Olympia), the bill’s sponsor, highlighted the logistical difficulties in distributing the medication, stating that the new legislation will help ensure the stockpile “actually goes to use” [GoSkagit.com]. The bill also directs the Department of Health to collaborate with the DOC in identifying appropriate recipients for the medications.

Legislative Support and Opposition

The bill passed the Senate with a vote of 32-17, receiving support from two Republicans alongside all Democrats [Spokesman.com]. However, some Republican lawmakers expressed concerns about the potential for Washington state to become a provider of abortion medication for the entire country, questioning the financial implications of widespread distribution [Spokesman.com].

Next Steps

SB 5917 now moves to the House of Representatives for consideration, with a hearing scheduled in the House Healthcare and Wellness Committee [Spokesman.com]. The legislation builds upon Senate Bill 5768, passed in 2023, which initially authorized the DOC to acquire and distribute abortion medications as a safeguard against potential federal restrictions [ncwlife.com].